Industry Insights

Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE – the first and only cleared and dedicated electrosurgical guidewire system to prevent coronary obstruction in patients undergoing Transcatheter Aortic Valve Replacement (TAVR) for both native aortic stenosis and bioprosthetic valve failure.

On November 21, the Centers for Medicare & Medicaid Services (CMS) released the 2026 Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) final rule. The Ambulatory Surgery Center Association (ASCA) supports key policy updates in the rule that will enhance beneficiary access to vital surgical services, lower costs for patients and reduce long-term spending for the Medicare program.

Viseon reports the first patient treated using Hubble EXCITE in a glioblastoma brain surgery by Dr. Ian Lee, Residency Program Director, Co-Director Hermelin Brain Tumor Center, Neurosurgeon at Henry Ford Health. The Hubble EXCITE device was used through a left parietal craniotomy for dissection and fluorescence guided imaging.

In collaboration with Microsoft, Mercy is playing a key role in the development of the first commercially available ambient AI solution for nurses within Microsoft Dragon Copilot.